APA (7th ed.) Citation

Middeke, J. M., & Klein, S. (2016). Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: Results of the BRIDGE trial. Leukemia, 30(2), . https://doi.org/10.1038/leu.2015.226

Chicago Style (17th ed.) Citation

Middeke, Jan Moritz, and Stefan Klein. "Clofarabine Salvage Therapy Before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory AML: Results of the BRIDGE Trial." Leukemia 30, no. 2 (2016). https://doi.org/10.1038/leu.2015.226.

MLA (9th ed.) Citation

Middeke, Jan Moritz, and Stefan Klein. "Clofarabine Salvage Therapy Before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory AML: Results of the BRIDGE Trial." Leukemia, vol. 30, no. 2, 2016, https://doi.org/10.1038/leu.2015.226.